ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,796Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1448

$1.11M Total Retail Price of All Prescriptions

Rank: 22 out of 1448

574 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

14% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 12,946 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 859 789 1 2
ATORVASTATIN CALCIUM 715 585 2 4
SIMVASTATIN 584 530 3 3
CARVEDILOL 553 492 4 1
LEVOTHYROXINE SODIUM 432 387 5 21
FUROSEMIDE 391 343 6 7
METFORMIN HCL 377 278 7 25
OMEPRAZOLE 364 314 8 23
ZETIA 360 313 9 28
HYDROCODONE-ACETAMINOPHEN 338 261 S3 10 33
BENAZEPRIL HCL 312 259 11 26
WARFARIN SODIUM 296 288 12 8
PRAVASTATIN SODIUM 266 262 13 20
CRESTOR 261 213 14 17
DIOVAN 259 230 15 15
POTASSIUM CHLORIDE 236 217 16 19
LOSARTAN POTASSIUM 203 182 17 11
ALENDRONATE SODIUM 203 203 17 41
TAMSULOSIN HCL 201 181 19 46
SPIRIVA 183 166 20 97
LISINOPRIL 177 135 21 5
LIPITOR 166 149 22 30
NIASPAN 164 158 23 47
AMLODIPINE BESYLATE-BENAZEPRIL 152 148 24 67
INSULIN SYRINGE 133 123 25 139
KLOR-CON 10 127 106 26 102
BENICAR 126 114 27 50
AMIODARONE HCL 124 120 28 22
SPIRONOLACTONE 119 115 29 24
RAMIPRIL 114 97 30 36
AVODART 110 90 31 120
ADVAIR DISKUS 107 64 32 74
ZOLPIDEM TARTRATE 106 88 33 34
LANTUS 100 91 34 111
EXFORGE 100 100 34 80
ACTOS 99 73 36 92
GABAPENTIN 97 94 37 51
RANEXA 95 66 38 37
FLUOXETINE HCL 94 87 39 164
METOPROLOL SUCCINATE 93 82 40 6
JANUVIA 88 67 41 64
CLOPIDOGREL 84 77 42 10
HYDROCHLOROTHIAZIDE 82 68 43 18
MULTAQ 78 66 44 57
ATENOLOL 78 60 44 12
CYMBALTA 75 65 46 123
WELCHOL 73 73 47 103
SERTRALINE HCL 68 68 48 99
PANTOPRAZOLE SODIUM 68 57 48 42
AZOR 66 66 50 125
TORSEMIDE 66 66 50 117
PLAVIX 65 61 52 14
BENICAR HCT 64 64 53 84
VESICARE 62 56 54 205
DILTIAZEM 24HR CD 59 47 55 61
GLIMEPIRIDE 58 41 56 66
CITALOPRAM HBR 56 46 57 129
KLOR-CON M10 56 52 57 312
XARELTO 55 54 59 58
METOPROLOL TARTRATE 53 49 60 9
PRADAXA 52 52 61 27
SPIRONOLACTONE-HCTZ 52 42 61 114
RISPERIDONE 51 51 63 224
GLYBURIDE 50 43 R 64 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.